Results 191 to 200 of about 98,172 (269)

The clinical significance of TAT, PIC, TM, and t-PAIC in vascular events of BCR/ABL-negative myeloproliferative neoplasms. [PDF]

Clin Exp Med
Huang K, Mo Q, Liao C, Feng S, Liu G, Jiang D, Lei P.   +6 more
europepmc   +1 more source

Abnormal integrin-mediated regulation of chronic myelogenous leukemia CD34 ⁺ cell proliferation: BCR/ABL up-regulates the cyclin-dependent kinase inhibitor, p27 ^Kip , which is relocated to the cell cytoplasm and incapable of regulating cdk2 activity

, 2000
Yuehua Jiang, Robert C.H. Zhao, Catherine M. Verfaillie   +2 more
openalex   +1 more source

Gambogic Acid Induces Apoptosis in Imatinib-Resistant Chronic Myeloid Leukemia Cells via Inducing Proteasome Inhibition and Caspase-Dependent Bcr-Abl Downregulation

Clinical Cancer Research, 2013
Xianping Shi, Xin Chen, Xiaofen Li, Xiaoying Lan, Chong Zhao, Shouting Liu, Hongbiao Huang, Ningning Liu, Siyan Liao, Wenbin Song, P. Zhou, Shunqing Wang, Li Xu, Xuejun Wang, Q. Dou, Jinbao Liu   +15 more
semanticscholar   +1 more source

Molecular Modeling of Single- and Double-Hydrocarbon-Stapled Coiled-Coil Inhibitors against Bcr-Abl: Toward a Treatment Strategy for CML. [PDF]

J Phys Chem B
Lima MCP, Hornsby BD, Lim CS, Cheatham TE.   +3 more
europepmc   +1 more source

BCR-ABL Prevents c-Jun-Mediated and Proteasome-Dependent FUS (TLS) Proteolysis through a Protein Kinase CβII-Dependent Pathway

, 2000
Danilo Perrotti, Angela Iervolino, Vincenzo Cesi, Maria Cirinnà, S. Lombardini, Emanuela Grassilli, Silvia Bonatti, Pier Paolo Claudio, Bruno Calabretta   +8 more
openalex   +1 more source

CrkL functions as a nuclear adaptor and transcriptional activator in Bcr-Abl–expressing cells

, 2000
Jennifer Rhodes, Randall D. York, David Tara, Katsu Tajinda, Brian J. Druker   +4 more
openalex   +1 more source

Concomitant L248V With E225V Mutation in the BCR-ABL Gene Associated With Rapid Chronic Myeloid Leukemia Lymphoid Blast Crisis. [PDF]

Cureus
Tungjitviboonkun S, Wachirapornpruet P, Unsuwan S.   +2 more
europepmc   +1 more source

FL118 Is a Potent Therapeutic Agent against Chronic Myeloid Leukemia Resistant to BCR-ABL Inhibitors through Targeting RNA Helicase DDX5. [PDF]

Int J Mol Sci
Takeda K, Ohta S, Nagao M, Kobayashi E, Tago K, Funakoshi-Tago M.   +5 more
europepmc   +1 more source